New drug combo takes on advanced cancers in first human trial
Disease control
Ongoing
This early-phase study tests an experimental drug called ANV600, given alone or with the immunotherapy Keytruda, in 240 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and see if the drug can shrink tumors. Beca…
Phase: PHASE1, PHASE2 • Sponsor: Anaveon AG • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC